Wellcome Leap Psilocybin for OUD

计划入组 36 人 · 首次发布于 2025 年 1 月 22 日

A Randomized Trial Comparing Matt and Antimicrobial Cellomed Laminates

计划入组 200 人 · 首次发布于 2010 年 11 月 23 日

Study of Cellutome System for Treatment of Individual Lesions in EB Pts

计划入组 34 人 · 首次发布于 2016 年 2 月 2 日

histamine H4 receptor antagonists (Cellzome)

Indolocarbazoles (Glaxo Wellcome)

GR-159897 analogs (Glaxo-Wellcome)

Burroughs Wellcome

United Kingdom

WELLCOME TRUST

United Kingdom

Glaxo Wellcome SA

Spain

Avacta Therapeutics Promotes Francis Wilson to Chief Scientific Officer to Lead pre|CISION Platform Development

Wellcome Leap's Quantum for Bio Program Advances Quantum Computing in Healthcare

£17.9 Million Wellcome Grant Funds Major Initiative to Combat Deadly Fungal Infections